Your Messages Inbox
Your Article Summary
See Latest ArticlesA Critical Appraisal of the Safety and Efficacy of Drug-Eluting Stents
Clinical Pharmacology & Therapeutics, 03/17/09
Maluenda G et al. - New generation DESs with novel polymers, antiproliferative drugs, and improved platforms are now approved and available for use. In this review authors provide a critical appraisal, based on published clinical data, of the safety and efficacy of various DESs.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/15/09
Second Pivotal Phase III Study of Gileads Darusentan for Resistant Hypertension Misses Primary Endpoints
Gilead, 12/15/09
Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Genentech, 12/15/09
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09
Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin
Roche, 12/14/09
Sanofi-aventis doubles syringe production capacity and diversifies vaccine production at the Le Trait Manufacturing Plant
Sanofi-aventis, 12/14/09
Article Search
Sponsor